Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 12, 1997

View Archived Issues

Proteome project collaboration announced

Bigmar to enter potential collaboration; Regains rights to oncology products

Xytronyx changes name to Pacific Pharmaceuticals

Organogenesis receives FDA clearance for Graftpatch

Studies imply role of relaxin in infertility treatments

Bristol-Myers Squibb: Q2 1997 highlights

Imminent launch of Novartis' Alzheimer's disease therapy

Normiflo launched in U.S.

Living wound care product launched in Canada

Amarillo Biosciences completes enrollment for phase II study on Sjogren's syndrome

Federal district court favors Geneva in ranitidine patent litigation

EntreMed and the National Cancer Institute sign letters of intent

Shaman: Q2 1997 highlights

New angiotensin II blocker from Merck KGaA

Bayer reports LTB4 synthesis inhibitors for asthma

MMP/TNF-alpha inhibitors from Novartis

RPR seeks U.S. and European approval for estrogen/progestogen transdermal patch

Settlement reached in NeXstar and The Liposome Company patent litigation

Lidak licenses ADIFAB technology to Aurora Biosciences

Lilly and Acacia Biosciences sign research collaboration

Briana Bio-Tech acquires breast cancer detection system

Cangene signs licensing and distribution agreement for Leucotropin

Diversa reaches milestone in Finnfeeds agreement

Andaris files IND application for Quantison